Cargando…
The value of blood cytokines and chemokines in assessing COPD
BACKGROUND: Blood biomarkers are increasingly used to stratify high risk chronic obstructive pulmonary disease (COPD) patients; however, there are fewer studies that have investigated multiple biomarkers and replicated in multiple large well-characterized cohorts of susceptible current and former sm...
Autores principales: | Bradford, Eric, Jacobson, Sean, Varasteh, Jason, Comellas, Alejandro P., Woodruff, Prescott, O’Neal, Wanda, DeMeo, Dawn L., Li, Xingnan, Kim, Victor, Cho, Michael, Castaldi, Peter J., Hersh, Craig, Silverman, Edwin K., Crapo, James D., Kechris, Katerina, Bowler, Russell P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655820/ https://www.ncbi.nlm.nih.gov/pubmed/29065892 http://dx.doi.org/10.1186/s12931-017-0662-2 |
Ejemplares similares
-
Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema
por: Gillenwater, Lucas A., et al.
Publicado: (2021) -
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021) -
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
por: Sun, Wei, et al.
Publicado: (2016) -
Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma
por: Halper-Stromberg, Eitan, et al.
Publicado: (2019) -
Meta-analysis of peripheral blood gene expression modules for COPD phenotypes
por: Reinhold, Dominik, et al.
Publicado: (2017)